A detailed history of Royal Bank Of Canada transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 19,258 shares of TMDX stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,258
Previous 9,725 98.03%
Holding current value
$3.02 Million
Previous $719,000 303.34%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $692,286 - $1.44 Million
9,533 Added 98.03%
19,258 $2.9 Million
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $1.21 Million - $1.54 Million
-17,134 Reduced 63.79%
9,725 $719,000
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $15,430 - $34,053
420 Added 1.59%
26,859 $2.12 Million
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $169,286 - $304,157
3,166 Added 13.6%
26,439 $1.45 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $372,345 - $498,840
5,622 Added 31.85%
23,273 $1.95 Million
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $700,997 - $1.08 Million
13,071 Added 285.39%
17,651 $1.34 Million
Q4 2022

Feb 14, 2023

BUY
$39.08 - $64.29 $135,138 - $222,314
3,458 Added 308.2%
4,580 $282,000
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $30,644 - $54,133
971 Added 643.05%
1,122 $46,000
Q2 2022

Aug 15, 2022

SELL
$20.56 - $32.15 $29,626 - $46,328
-1,441 Reduced 90.52%
151 $5,000
Q1 2022

May 16, 2022

SELL
$12.58 - $26.94 $44,696 - $95,717
-3,553 Reduced 69.06%
1,592 $43,000
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $40,791 - $69,575
2,129 Added 70.59%
5,145 $98,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $33,747 - $44,932
-1,302 Reduced 30.15%
3,016 $100,000
Q2 2021

Aug 16, 2021

BUY
$21.63 - $40.07 $93,398 - $173,022
4,318 New
4,318 $144,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $5B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.